Akebia Therapeutics Inc (AKBA)
1.33
+0.01
(+0.76%)
USD |
NASDAQ |
Oct 04, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Shareholders Equity (Annual): -30.58M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -30.58M |
| December 31, 2022 | 5.23M |
| December 31, 2021 | 74.01M |
| December 31, 2020 | 247.62M |
| December 31, 2019 | 394.76M |
| December 31, 2018 | 635.93M |
| Date | Value |
|---|---|
| December 31, 2017 | 122.57M |
| December 31, 2016 | 68.12M |
| December 31, 2015 | 131.00M |
| December 31, 2014 | 104.08M |
| December 31, 2013 | 30.76M |
| December 31, 2012 | -2.680M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-30.58M
Minimum
2023
394.76M
Maximum
2019
138.21M
Average
74.01M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Corcept Therapeutics Inc | 506.70M |
| Bioventus Inc | 173.59M |
| Eli Lilly and Co | 10.77B |
| Pfizer Inc | 89.01B |
| Cara Therapeutics Inc | 57.08M |